These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17047253)

  • 21. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis.
    Woodrow G; Stables G; Oldroyd B; Gibson J; Turney JH; Brownjohn AM
    Nephrol Dial Transplant; 1999 Jun; 14(6):1530-5. PubMed ID: 10383020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
    Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
    Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of icodextrin in high transport ultrafiltration failure.
    Krediet R; Mujais S
    Kidney Int Suppl; 2002 Oct; (81):S53-61. PubMed ID: 12230482
    [No Abstract]   [Full Text] [Related]  

  • 24. Long daytime exchange in children on continuous cycling peritoneal dialysis: preservation of drained volume because of icodextrin use.
    Michallat AC; Dheu C; Loichot C; Danner S; Fischbach M
    Adv Perit Dial; 2005; 21():195-9. PubMed ID: 16686317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study.
    Dallas F; Jenkins SB; Wilkie ME
    Perit Dial Int; 2004; 24(6):542-6. PubMed ID: 15559483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Icodextrin--what about the fractions?
    Wilkie M
    Perit Dial Int; 2005; 25(2):161-2. PubMed ID: 15796144
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.
    Wolfson M; Piraino B; Hamburger RJ; Morton AR;
    Am J Kidney Dis; 2002 Nov; 40(5):1055-65. PubMed ID: 12407652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis.
    Sav T; Oymak O; Inanc MT; Dogan A; Tokgoz B; Utas C
    Perit Dial Int; 2009; 29(4):443-9. PubMed ID: 19602610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism.
    Bredie SJ; Bosch FH; Demacker PN; Stalenhoef AF; van Leusen R
    Perit Dial Int; 2001; 21(3):275-81. PubMed ID: 11475343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diuretic-resistant congestive heart failure treated successfully with peritoneal ultrafiltration.
    Próchnicka A; Krzesiński P; Hałas K; Dziuk M; Niemczyk S; Wańkowicz Z
    Kardiol Pol; 2013; 71(4):393-5. PubMed ID: 23788345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Volume-Based Peritoneal Dialysis Prescription Guide to Achieve Adequacy Targets.
    Akonur A; Firanek CA; Gellens ME; Hutchcraft AM; Kathuria P; Sloand JA
    Perit Dial Int; 2016; 36(2):188-95. PubMed ID: 26293841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
    Qi H; Xu C; Yan H; Ma J
    Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of icodextrin to provide adequate ultrafiltration in continuous ambulatory peritoneal dialysis patients.
    Thodis E; Passadakis P; Panagoutsos S; Marinopoulos D; Vargemezis V
    Adv Perit Dial; 1999; 15():171-4. PubMed ID: 10682096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sterile peritonitis due to icodextrin: experience from a Canadian center.
    Poulopoulos V; Lam L; Cugelman A
    Perit Dial Int; 2004; 24(1):88-9. PubMed ID: 15104348
    [No Abstract]   [Full Text] [Related]  

  • 36. Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution.
    MacGinley R; Cooney K; Alexander G; Cohen S; Goldsmith DJ
    Am J Kidney Dis; 2002 Nov; 40(5):1030-5. PubMed ID: 12407649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocytic vasculitis associated with icodextrin.
    Mondello S; Buemi M; Mazzon E; Aloisi C
    Perit Dial Int; 2007; 27(6):712-5. PubMed ID: 17984440
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneal reaction to icodextrin in a female patient on CAPD.
    Heering P; Brause M; Plum J; Grabensee B
    Perit Dial Int; 2001; 21(3):321-2. PubMed ID: 11475354
    [No Abstract]   [Full Text] [Related]  

  • 40. Icodextrin: fifteen years and counting. Introduction.
    Blake PG
    Perit Dial Int; 2009; 29(4):367-9. PubMed ID: 19725196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.